Genes, fuel, and fate in lung cancer
Open Access
- 6 October 2026
- journal article
- Published by Portland Press Ltd. in Biochemical Society Transactions
- Vol. 54 (10) , 1419-1430
Abstract
Cellular plasticity is a central feature of malignant progression, allowing tumour cells to change identity during tumour evolution, therapeutic adaptation, and metastatic dissemination. This issue is especially acute in lung cancer, where the respiratory epithelium is intrinsically permissive to cell-state change. Genetic lesions, chromatin regulation, and metabolic adaptation are often framed as parallel determinants of lineage plasticity. Emerging evidence instead points to functional coupling across these layers. Oncogenic alterations can weaken lineage fidelity and open alternative trajectories, chromatin regulators can stabilise transitional states and enforce new transcriptional programmes, and metabolic rewiring can supply the biochemical conditions required for these states to emerge and persist. Microenvironmental cues further influence which trajectories are selected and maintained. Here, we discuss the genetic, epigenetic, and metabolic determinants of lineage plasticity in lung cancer, focusing on the points at which they intersect. We propose that plasticity is most usefully understood as a coupled regulatory state, arising from the interaction between oncogenic context, chromatin control, and metabolic support. Defining how these dependencies arise and become functionally coupled within high-plasticity transitional states should help identify points at which lineage switching can be intercepted before alternative lineage programmes are stabilised.Keywords
Funding Information
- EC | Horizon Europe | Excellent Science | HORIZON EUROPE Marie Sklodowska-Curie Actions (101207862)
- KWF Kankerbestrijding (14834)
This publication has 101 references indexed in Scilit:
- Spatial omics at the forefront: emerging technologies, analytical innovations, and clinical applicationsCancer Cell, 2025
- Adeno-to-squamous transition drives resistance to KRAS inhibition in LKB1 mutant lung cancerCancer Cell, 2024
- Oncogene-addicted metastatic non-small-cell lung cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-upAnnals of Oncology, 2023
- Emergence of a High-Plasticity Cell State during Lung Cancer EvolutionCancer Cell, 2020
- Epigenetic modulations and lineage plasticity in advanced prostate cancerAnnals of Oncology, 2020
- Significantly mutated genes and regulatory pathways in SCLC—a meta-analysisCancer Genetics, 2017
- Metabolic Heterogeneity in Human Lung TumorsCell, 2016
- LKB1 Inactivation Elicits a Redox Imbalance to Modulate Non-small Cell Lung Cancer Plasticity and Therapeutic ResponseCancer Cell, 2015
- LKB1 Inactivation Dictates Therapeutic Response of Non-Small Cell Lung Cancer to the Metabolism Drug PhenforminCancer Cell, 2013
- Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell DeathCell, 2012